Arkolith/Insider Trading/DTIL/Form 4

Amoroso Michael

President and CEO, DirectorPRECISION BIOSCIENCES INC (DTIL) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$145K
Net Open-Market Flow
-$145K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Sell(S)35K$4.17$145K196K
Jan 20, 2026Option exercise(M)37K——162K
Jan 20, 2026Option exercise(M)9K——124K
Jan 20, 2026Option exercise(M)69K——231K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2026Option exercise(M)37K—$037K
Jan 20, 2026Option exercise(M)9K—$00
Jan 20, 2026Option exercise(M)69K—$069K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003149) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML